Joseph K. Belanoff owns 2.65% of Corcept Therapeutics
2,865,489 shares as of the June 1, 2026 filing, worth $316M at the latest close.
CORT · $11.9B market cap · Founder-ledGet an email when Joseph K. Belanoff’s stake moves.
Free.
The stake
2.65%
worth $316M at the latest close
Stake rank
#208
by dollar value of the stake
Last sale
140 days ago
Jun 1, 2026
Last buy
None
no purchases since 2016
Joseph K. Belanoff owns 2.65% of CORCEPT THERAPEUTICS INC: 2,865,489 of 108,098,397 shares, worth about $316M at the 2026-10-16 close. The stake has moved from 2.52% in 2016 to 2.65% on 2026-07-22, across 16 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $895,252 on 2026-06-01.
How the stake is held
as of the Jun 1, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Jun 1, 2026 · Form 4 ↗
HELD INDIRECTLY · 3 VEHICLES
2,865,489
100.0%
Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
2,565,489
89.5%
Joseph K. Belanoff 2026 Grantor Retained Annuity Trust
150,000
5.2%
Katherine A. Blenko 2026 Grantor Retained Annuity Trust
150,000
5.2%
THE STAKE
2,865,489
2.65%